* Low attenuation plaque is a subset of non-calcified plaque and is not added separately to the total.
Overall Totals (auto-calculated)
mm³
%
mm³
%
mm³
%
mm³
2
Base Risk Stage
Auto-determined from Total Plaque Volume
Mild1–100 mm³
Moderate>100–250 mm³
Severe>250–750 mm³
Extensive>750 mm³
3
Nomogram Percentile & Risk Enhancers
Potential upstaging based on percentile and clinical risk factors
th %ile
If >50th percentile, the patient is automatically upstaged. If percentile is not known, use the calculator below to look it up by age, sex, and total plaque volume.
Note for radiologists: As imaging physicians, we may not have access to the patient's full clinical history. The generated report will include a note that the referring clinician should assess for risk enhancers that may warrant upstaging.
Risk enhancers include: Family history of premature ASCVD, primary hypercholesterolemia, metabolic syndrome, chronic kidney disease, chronic inflammatory conditions, history of premature menopause, pregnancy-associated conditions that increase later ASCVD risk, high-risk race/ethnicity, lipids/biomarkers associated with increased ASCVD risk.
4
Final Stage
Effective stage after upstaging considerations
Enter plaque volumes above to determine final stage.
5
Medical Management Recommendations
Based on final stage per the DECIDE registry framework
Determined by final stage above.
DECIDE Registry: Medical management recommendations are informed by the DECIDE (Artificial Intelligence–Enabled CT-Derived Plaque Analysis for Guiding Preventive Care) registry framework, the largest prospective study investigating how HeartFlow's AI-enabled Plaque Analysis informs medical management. AI-enabled Plaque Analysis led to medical management change in over half of patients beyond CCTA alone. For additional information, see Tzimas et al. and the DECIDE registry primary endpoint data presented at SCCT 2025.
✎
Generated Report Text
Fill in the fields above and click "Generate Report".
Reference 1 — Disease Severity Staging + Standard Medical Management
Reference 2 — QCPA Report Example (Plaque Assessment)
Reference 3 — QCPA Report Example (LDL Goals & Rx)